Redhill Biopharma Ltd.
A specialty biopharmaceutical company based in Tel Aviv, Israel, that develops and sells prescription drugs for stomach, gut, and infectious diseases. Its flagship product, Talicia, is a single capsule that packs three medicines to wipe out the H. pylori stomach infection, and it also markets Movantik for opioid-induced constipation. Founded in 2009 by Dror Ben-Asher, the company grew out of his earlier work in pharmaceutical finance and has never publicly explained the story behind its "RedHill" name.
American Depositary Shares, each representing 10,000 ordinary shares